Amgen (AMGN) Debt Ratio (2009 - 2026)
Amgen (AMGN) posted Debt Ratio of 0.66 for Q2 2026, down 3.29% on a QoQ basis from 0.68 in Q1 2026, and down 1.67% year-over-year from 0.67 in Q2 2025.
Analysis
Amgen (AMGN) Debt Ratio (2009 - 2026) Analysis & Trends
Amgen has reported Debt Ratio for 18 years, with the latest figure at 0.66 in Q2 2026.
- On a quarterly basis, Debt Ratio fell 1.67% year-over-year to 0.66 in Q2 2026; TTM through Jun 2026 was 0.66, a 1.67% decrease from a year earlier, with the FY2025 full-year figure at 0.65, down 5.7% from the prior year.
- Debt Ratio was 0.66 for Q2 2026 at Amgen, down from 0.68 in the prior quarter.
- The five-year high for Debt Ratio was 0.75 in Q2 2024, with the low at 0.62 in Q4 2022.
- Average Debt Ratio over 5 years is 0.67, with a median of 0.68 recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: Debt Ratio grew 16.4% in 2022, then slipped 11.03% in 2025.
- Over 5 years, Debt Ratio stood at 0.62 in 2022, then increased by 9.23% to 0.68 in 2023, then rose by 1.93% to 0.69 in 2024, then fell by 5.7% to 0.65 in 2025, then rose by 0.39% to 0.66 in 2026.
- The last three Debt Ratio figures came in at 0.66 (Q2 2026), 0.68 (Q1 2026), and 0.65 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn | 0.05 |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | 0.05 |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 0.25 |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn | - |
| 10 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 0.26 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.66 |
| Mar 31, 2026 | 0.68 |
| Dec 31, 2025 | 0.65 |
| Sep 30, 2025 | 0.63 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | 0.68 |
| Dec 31, 2024 | 0.69 |
| Sep 30, 2024 | 0.70 |
| Jun 30, 2024 | 0.75 |
| Mar 31, 2024 | 0.73 |
| Dec 31, 2023 | 0.68 |
| Sep 30, 2023 | 0.68 |
| Jun 30, 2023 | 0.71 |
| Mar 31, 2023 | 0.70 |
| Dec 31, 2022 | 0.62 |
| Sep 30, 2022 | 0.63 |
| Jun 30, 2022 | 0.63 |
| Mar 31, 2022 | 0.64 |
| Dec 31, 2021 | 0.55 |
| Sep 30, 2021 | 0.64 |